Evidence map›Paper›PMID 35052645›Full record

ArticleAntioxidants (Basel, Switzerland)2022

Hee-Young Kim, Chang-Hwan Bae, Jayoung Kim, Yukyoung Lee, Hyongjun Jeon, Hyungwoo Kim, Seungtae Kim

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. International journal of molecular sciences · 2023
    Article
  5. Frontiers in pharmacology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Hee-Young KimKorean Medicine Research Center for Healthy Aging, Pusan National University, Yangsan 50612, Korea.ORCID 0000-0002-2637-8621
Chang-Hwan BaeDepartment of Korean Medical Science, School of Korean Medicine, Pusan National University, Yangsan 50612, Korea.
Jayoung KimDepartment of Convergence Medicine, School of Medicine, Pusan National University, Yangsan 50612, Korea.ORCID 0000-0002-2810-849X
Yukyoung LeeDepartment of Korean Medical Science, School of Korean Medicine, Pusan National University, Yangsan 50612, Korea.
Hyongjun JeonDepartment of Korean Medical Science, School of Korean Medicine, Pusan National University, Yangsan 50612, Korea.ORCID 0000-0001-5806-7935
Hyungwoo KimDivision of Pharmacology, School of Korean Medicine, Pusan National University, Yangsan 50612, Korea.
Seungtae KimKorean Medicine Research Center for Healthy Aging, Pusan National University, Yangsan 50612, Korea.ORCID 0000-0001-6033-5847
Pusan National University · KR

Funding

National Research Foundation of Korea NRF-2019R1A2C1085130National Research Foundation of Korea NRF-2021R1A4A1025662National Research Foundation of Korea NRF-2021R1I1A1A01044890
6 · The paper itself

Abstract

Parkinson's disease (PD) is the second most common neurodegenerative disease worldwide.

Indexed as

gut–brain axisMPP+MPTPneurodegenerationneuroinflammationParkinson’s diseaseRumex japonicus Houtt.SH-SY5Ytight junctionα-synuclein

Identifiers

PMID35052645
PMCPMC8772800
OpenAlexW4206739890

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.